Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway.

作者: Tsung-Ching Lai , Chih-Yeu Fang , Yi-Hua Jan , Hsiao-Ling Hsieh , Yi-Fang Yang

DOI: 10.1186/S12964-020-00600-2

关键词:

摘要: … expression enhanced the paclitaxel resistance of breast cancer cells via the NF-κB signaling pathway. However, the mechanism of TAOK3-NF-κB-PTGS2 pathway remains unclear. …

参考文章(55)
Jianzhong Xi, Miyong Yun, Duckgue Lee, Moon-Nyeo Park, Eun-Ok Kim, Eun Jung Sohn, Byung-Mog Kwon, Cinnamaldehyde derivative (CB-PIC) sensitizes chemo-resistant cancer cells to drug-induced apoptosis via suppression of MDR1 and its upstream STAT3 and AKT signalling. Cellular Physiology and Biochemistry. ,vol. 35, pp. 1821- 1830 ,(2015) , 10.1159/000373993
Amelia Zelnak, Overcoming taxane and anthracycline resistance. Breast Journal. ,vol. 16, pp. 309- 312 ,(2010) , 10.1111/J.1524-4741.2010.00911.X
Lucia D''Antona, Rosario Amato, Cristina Talarico, Francesco Ortuso, Miranda Menniti, Vincenzo Dattilo, Rodolfo Iuliano, Francesco Gigliotti, Anna Artese, Giosuè Costa, Silvia Schenone, Francesca Musumeci, Claudia Abbruzzese, Lorenzo Botta, Francesco Trapasso, Stefano Alcaro, Marco G. Paggi, Nicola Perrotti, SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation. Cellular Physiology and Biochemistry. ,vol. 35, pp. 2006- 2018 ,(2015) , 10.1159/000374008
Michele Hutchison, Kevin S. Berman, Melanie H. Cobb, Isolation of TAO1, a Protein Kinase That Activates MEKs in Stress-activated Protein Kinase Cascades * Journal of Biological Chemistry. ,vol. 273, pp. 28625- 28632 ,(1998) , 10.1074/JBC.273.44.28625
Mary Ann Jordan, Leslie Wilson, Microtubules as a target for anticancer drugs. Nature Reviews Cancer. ,vol. 4, pp. 253- 265 ,(2004) , 10.1038/NRC1317
Tony Hunter, Treatment for chronic myelogenous leukemia: the long road to imatinib Journal of Clinical Investigation. ,vol. 117, pp. 2036- 2043 ,(2007) , 10.1172/JCI31691
K. E. Gascoigne, S. S. Taylor, How do anti-mitotic drugs kill cancer cells? Journal of Cell Science. ,vol. 122, pp. 2579- 2585 ,(2009) , 10.1242/JCS.039719
S. Murray, E. Briasoulis, H. Linardou, D. Bafaloukos, C. Papadimitriou, Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treatment Reviews. ,vol. 38, pp. 890- 903 ,(2012) , 10.1016/J.CTRV.2012.02.011
Q Yang, J Huang, Q Wu, Y Cai, L Zhu, X Lu, S Chen, C Chen, Z Wang, Acquisition of epithelial-mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells. British Journal of Cancer. ,vol. 110, pp. 1958- 1967 ,(2014) , 10.1038/BJC.2014.136
Jun-ichi Okano, Anil K. Rustgi, Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery Journal of Biological Chemistry. ,vol. 276, pp. 19555- 19564 ,(2001) , 10.1074/JBC.M011164200